Erectile dysfunction following prostate ablative therapy

This code represents the inability to achieve or maintain an erection sufficient for satisfactory sexual performance, specifically when this condition arises as a direct consequence of prostate ablative therapy. This includes procedures such as radical prostatectomy, cryotherapy, or radiation therapy for prostate cancer.

Apply this code when documentation clearly links erectile dysfunction to a history of prostate ablative treatment. This diagnosis is appropriate for patients experiencing new-onset or exacerbated ED post-prostate cancer treatment. Supporting documentation should include a history of the ablative therapy and a diagnosis of ED.

• Always sequence this code after the primary diagnosis for the prostate cancer if the patient is still under active treatment or surveillance for the malignancy.
• Ensure documentation explicitly states the "following prostate ablative therapy" etiology; otherwise, a general ED code (e.g., N52.1, N52.9) may be more appropriate.
• Do not confuse with ED due to other causes, such as diabetes or vascular disease, unless those are also present and documented as contributing factors.